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Introduction
Iatrogenic femoral artery lesions following diag-
nostic or interventional angiography and coronarog-
raphy procedures are becoming more frequent for the
considerable increased number of the procedures per-
formed worldwide. In fact, different reports during
the last years showed an incidence of these lesions
that ranged between 1 and 15% (1).
The increasing number of iatrogenic femoral
artery lesions, mainly represented by hemorrhagic or
thromboembolic complications, is due on the one
hand to the enormous increase of the number of the
procedures, and on the other hand to the particular
pathological conditions of the arterial wall (diffuse
atherosclerosis) and the associated antiplatelet or anti-
coagulant therapy. As a consequence, during the last
years, many Authors reports an increased incidence of
emergency operations on high risk patients with a
huge increase of costs and hospital staying.
During the last years different types of percuta-
neous arterial closure devices (Angioseal, Prostar,
Techstar, Vasoseal) were developed in order to reduce
the incidence of these complications (2/3). At the
present, the frequent employment of these arterial
closure devices was followed by increased observation
of complications due to the device utilization itself.
Frequently the vascular surgeon decision of how to
treat these complications (ischemic, hemorrhagic or
RIASSUNTO: Trattamento dell’ischemia acuta degli arti inferiori secon-
daria all’impiego dei sistemi d’emostasi percutanea: nostra esperienza.
A. SIANI, A. SCHIOPPA, I. FLAISHMAN, A. ROSSI, A. ZACCARIA
Introduzione: Gli Autori riportano la propria esperienza nel
trattamento delll’ischemia acuta degli arti inferiori secondaria
all’impiego dei sistemi di emostasi percutanea.
Pazienti e metodi: Cinque pazienti sono stati sottoposti ad inter-
vento chirurgico in urgenza per ischemia acuta. L’ischemia è com-
parsa meno di un’ora dalla procedura in un paziente, dopo 4-12 ore
in due pazienti, oltre 24-36 ore in due pazienti. In tutti i casi sono
state eseguite angiografia preoperatoria ed embolectomia femorale. In
tre casi si è eseguita  una sutura diretta, in due una ricostruzione con
patch venoso. In un caso è stata eseguita endoarterectomia della
femorale comune
Risultati: Non si è osservata  mortalità operatoria e si è ottenuto
in tutti i casi  il salvataggio dell’arto. 
Conclusioni: Il  trattamento dell’ischemia acuta da sistemi
d’emostasi percutanea richiede un approccio chirurgico  esteso con ne-
cessità di ricostruzione in  ambiente a rischio settico. Riteniamo che
l’angiografia preoperatoria sia essenziale, preferendo sempre la sutura
diretta o l’impiego di patch venoso.
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Introduction: The Authors reports their experience in the mam-
agement of acute lower limb ischemia following percutaneous arterial
closure device application. 
Patient and methods: Five patients required an emergency vas-
cular operations for acute lower limb ischemia. The symptoms onset
was < 1 hour in 1 case, 4-12 hours in 2 cases and > 24-36 hours in
2 cases. A preoperative angiography was performed in all the cases. A
transfemoral embolectomy was carried out. Direct suture repair were
performed in three cases, vein patch angioplasty was carried out in
two cases. In one case, a common femoral artery endarterectomy was
performed. 
Results: No post-operative mortality and limb loss occurred.
Conclusions: Acute lower limb ischemia due to closure devices
required an extensive approach with reconstruction in high risk septic
area. Angiography is mandatory for surgical strategies. We prefer direct
suture repair and vein path angioplasty for vascular reconstruction.
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infective) is not easy because of small experience with
these devices on the one hand, and the only few
reports regarding the treatment of choice on the other
hand.
Aim of our study was to evaluate the treatment of
choice during acute lower limb ischemia following
the employment of percutaneous arterial closure
device and to review the literature.
Patients and methods
Between January 2003 and May 2005,  2500 diagnostic and
interventional angiographic and coronarographic procedures
through a femoral artery approach were performed at our
Hospital. In 270 cases (10.8%) an Angioseal percutaneous sutur-
ing devices have been used. In 180 cases (66.6%) a  interventional
coronary procedures were performed, while  in 90 cases (33.4%)
the procedure was only diagnostic.
In five cases (1.8%, 3 male and 2 female) the application of
Angioseal arterial closure device was followed by the onset of an
acute lower limb ischemic. In 2 cases stage II obstructive arteri-
opathy was present prior to the procedure. The clinical presenta-
tion was characterized in all patients by acute ischemia of the
right lower limb. The time interval between the application of the
arterial closure device and the symptoms onset was < 1 hour in 1
case, 4-12 hours in 2 cases and > 24-36 hours in 2 cases.
Prior to the operation, all patients underwent a diagnostic
angiographic exam at the operating room through the contra-lat-
eral femoral artery. The angiography findings showed a complete
occlusion on the common femoral artery in 2 cases (Figs. 1 and
2), a complete occlusion of the superficial femoral artery in 2
cases  and a popliteal artery embolization in 1 case.
All the operations were carried out under local anesthesia.
After the isolation of the femoral arteries we observed in 3 cases
the presence of subadventitial hematoma of the superficial
femoral artery at the point of the arterial closure device applica-
tion. In additional 2 cases, with major interval time between the
application and the clinical onset, the findings were characterized
by the presence of intensive reaction of the periarterial tissues
with a common femoral artery involved by a huge subadvential
hematoma. In this patient the hematoma extended for about 2
cm involving the femoral bifurcation and producing a “clepsydra”
deformation of the artery.
In 3 cases in which there were no intense parietal calcifica-
tions we performed a transverse arteriotomy at the point of the
closure device application. The exploration of the arterial lumen
showed the presence of thrombus adherent to the device itself.
After the thrombus removal, a thromboembolectomy according
Fogarty of the superficial and profunda femoral arteries was car-
ried out with the extraction of thrombotic material and the
restoration of good backflow. In other 2 cases, because of the exis-
tence of intense parietal atherosclerosis and a severe arteriopathy,
a longitudinal arteriotomy was carried out. In 1 patient, in addi-
tion to the thrombotic material at the site of the device applica-
tion, we found a wide dissection of the posterior arterial wall due
to a atherosclerosis plaque rupture. In this case we performed an
endarterectomy of the common femoral artery extended to the
end of the plaque and associated to the application of 6/0 Kunlin
suture. The arteriotomy was sutured with autologous saphena
vein (ASV) patch using a 5/0 monofilament suture. In 1 patient
we observed a small flap of the posterior wall that was sutured
with 6/0 Kunlin stitches. An ASV patch was applied also in this
patient. In both cases a thromboembolectomy according Fogarty
of the profound femoral artery was carried out previous to the
arterial wall suture.
No patient required a decompression fasciotomy.
Results
There were no case of post-operative death. Limb
salvage was achieved in all cases with no need for sec-
ond revascularization procedures. In 1 case a post-
A. Siani e Coll.
120
Fig. 2 - The angiography showed a complete occlusion of the right com-
mon femoral artery. 
Fig. 1 - The angiography showed an occlusion of the right common femo-
ral artery with profunda and superficial femoral arteries  riabitation. 
operative groin hematoma, managed by conservative
treatment, was present for a peri-operative minor
complication rate of 20%. There were no case of
major complications and no infection were observed
at the side of the artery closer device application.  
Follow-up was carried out for a mean period of
16 months. A color-duplex scan was performed at 1,
3, 6 and 12 months post-operativally and showed a
complete patency of the artery at the arterial closure
device application with no hyperplasic reaction of the
arterial wall.
Discussion
During the last decades a considerable increase in
the number of invasive diagnostic and interventional
angiographic procedures was registrated in part
because of their low morbidity and mortality rates
and because of extended indications. In parallel, sev-
eral authors reported an increased complications rate
following these procedures. These complications are
represented mainly by hemorrhagic disorders,
pseudoaneurysms and arteriovenous fistula formation
and thromboembolic events with acute lower limb
ischemia. Currently, most series reports a complica-
tions rate between 1% and 15%. In the USA Wong
et. al. reported the need for surgery because of com-
plications following angiography of 75.000 opera-
tions/year (4, 5). 
During the last years, the introduction of percuta-
neous arterial closure devices, by improving the he-
mostasis quality at the arterial puncture site,  offered
the possibility to achieve a more rapid mobilization of
the patients,  to reduce hospital staying costs, and the
possibility to use more efficient anticoagulant therapy
following these procedures.
Angioseal is actually one of the most frequently
employed percutaneous arterial closure device. The
device is made out of 3 parts: a flat anchor of 2x10
mm size of polylactic acid and polyglycolic acid, a
collagen plug and a connection system of polyglycolic
acid. The anchor is introduce to the arterial lumen
through a catheter while the collagen plug is posi-
tioned on the subadventitial surface. In succession,
the collagen plug is pushed against the arterial wall
and permits the hemostasis. 
The introduction of these hemostatic systems is
actually responsible to the occurrence of new group of
complications following diagnostic or interventional
angiography. These complications are represented
mainly by hemorrhagic, ischemic and infective events
and may be due in part to the  learning curve, to the
poor patients selection and to the dysfunction of the
device itself. The hemorrhagic complication rate
reported by several Authors is actually between 2%
and 9% (6, 7) and they mainly cause the formation of
pseudoaneurysms. In our series we never observed
this complication; Sprouse et al. (8) reported that this
kind of complication is not easy to manage. In fact,
these pseudoaneurysms are generally of big dimen-
sions, frequently with a diameter > 6 cm, with inten-
sive peri-arterial fibrosis and a high potential of infec-
tion. According to Sprouse experience a proximal iliac
artery control is often required and frequently a sim-
ple arterioraphy to close the arterial wall interruption
is non appropriate. In most cases a more complex
arterial reconstruction is necessary with increased
blood lose and increased post-operative morbidity
due to the cutaneous tissue damage (9). 
Similar difficulties are often present when manag-
ing the ischemic complications. There are two mecha-
nisms through which the Angioseal device can cause
ischemia. The first one, which was present in 3 of our
patients, is represented by thrombosis or distal
embolization without arterial wall lesions. In the sec-
ond one there is a thrombosis due to the anchorage of
a lateral plaque (formation of a clepsydra stenosis) or
a posterior plaque with occlusion or arterial wall dis-
section. It is of fundamental importance to make a
correct differential diagnosis between these two mech-
anisms in order to select the appropriate surgical tech-
nique. 
The management of ischemic complications with-
out arterial wall lesions appears to be less difficult. In
fact, in these instances, through a transverse arterioto-
my it is possible to carry out an embolectomy accord-
ing Fogarty to remove of the Angioseal anchorage sys-
tem  and to control the posterior arterial intimal layer.
In this way, by avoiding a longitudinal arteriotomy,
there is no need to apply a prosthetic or autologous
material for the arterial reconstruction. Since most of
the devices are applied on the superficial femoral
artery, with a reduce diameter as compared to the
common femoral artery,  the risk of stenosis caused by
a direct suture of a longitudinal arteriotomy is high.
Neheler et al. (10) in their experience showed that
arterial closure devices often create a potential septic
habitat. Similar conditions were observed by Sprouse
et al. (8) who reported cases of autologous saphenous
vein patch infection treated by transobturator bypass
or hip disarticulation, both procedures carried out
with high mortality rates.
Therefore, it is essential to performe the transverse
arteriotomy exactly above the anchorage position in
order to achieve a perfect control of the posterior
arterial intimal layer. In fact, these intimal lesions are
always to be controlled before closing the artery and
in case of lesion a Kunlin sutures can be applied. In
cases with posterior intimal lesions more distal to the
arteriotomy point it is possible to access them throu-
gh the extension of the transverse arteriotomy.  
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Other prefers to approach the lesion trough a pri-
mary longitudinal arteriotomy. One of the reasons is
that in the point of the closure device often there is a
chronic endarteritis which can cause late bleeding.
The second motivation is that the posterior extension
of the transverse arteriotomy may cause an arterial
wall rupture because of the presence of posterior ath-
erosclerotic plaques. In addition, because most groups
do not perform an arteriography of the femoral ves-
sels, seldom there is a need to convert a transverse
arteriotomy into a longitudinal arteriotomy in the
presence of severe arterial wall lesions and conse-
quently artery reconstruction difficulties. Therefore,
according to our experience and the literature review
this surgical approach epresents the most advanta-
geous, rapid and less traumatic choice from the tech-
nical point of view.   
About the pre-operative arteriography, although it
is not performed routinely in patients with acute lower
limb ischemia, we consider it very helpful by giving
information regarding the physiopathological mecha-
nism of the ischemia and helping the surgical strate-
gies to choose. In fact, it is of fundamental importance
to know if the ischemia is caused by steno-occlusion
or thrombo-embolization mechanisms.
In our experience we had two cases of acute
femoral artery thrombosis both in patients with ather-
osclerotic arteriopathy due to a parietal lesion caused
by the internal anchorage system and a posterior wall
plaque. In these two cases we used a longitudinal arte-
riotomy in order to achieve a better control of the
posterior artery wall. In one case we applied a Kunlin
suture to secure the intimal flaps. In the second case
we performed a common femoral artery endarterecto-
my because of the sever lesions of the arterial wall and
in order to achieve a better control of the distal end-
point. In both cases the arterial closure was carried
out with an ASV patch.
Because of the possible infective complications,
often caused by meticilin-resistant Staphyclococcus
aureus, we prefer to use autologous materials even if
they may cause degenerative alterations in the long
term follow-up. This approach reduces the high mor-
bidity and mortality rates associated with groin graft
infections (11-13).
Conclusion
It is our opinion that percutaneous arterial closure
devices represent advantageous and reliable systems to
be applied in selected patients.
The management of the complications following
the use of these systems is often difficult because of
the frequent presence of severe atherosclerotic lesions
and the high risk of infections. In patients with acute
lower limb ischemia it is mandatory to understand
the etiologic mechanism by performing a pre-opera-
tive arteriography. From the technical point of view
we prefer, when possible, a transverse arteriotomy and
an autologous vein graft when an arterial reconstruc-
tion is needed.  
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